Evry, France, July 4, 2016 -- Global Bioenergies obtains a €400,000 grant from the German Federal Ministry of Research and Education (BMBF) to produce renewable gasoline additives - Audi will use these for engine testing
Leuna (Germany), 04 July 2016 - Global Bioenergies announces today that its German subsidiary, Global Bioenergies GmbH, secured a €400.000 grant from the BMBF (the German federal ministry for research and education) to finance a 14 month-project aimed at producing renewable gasoline additives.
The Company will first produce ETBE, a molecule obtained by the condensation of ethanol and isobutene, and presently used as a gasoline additive in large volumes (worldwide market: 3.4 million tons per year). Today, ETBE is only half renewable, as the isobutene used to produce it is derived from oil. For the first time ever, 100% renewable ETBE will be produced at laboratory scale, with the collaboration of the Fraunhofer CBP institute: Isobutene produced at Global Bioenergies' Pomacle pilot plant will be converted into ETBE at the Leuna-based Fraunhofer CBP institute, which will then be shipped to Audi for laboratory testing.
The company will then convert the first batches of bio-isobutene to be produced from the Leuna Demo plant into large enough quantities of renewable isooctane for running preliminary engine testing at Audi.
Reiner Mangold, Head of Sustainable Product Development at Audi, states: "The samples received last year from Global Bioenergies are now validated analytically. We are eager to receive larger batches to run preliminary engine testing. Our collaboration with Global Bioenergies, to develop e-gasoline (Audi e-benzin) is getting up to speed."
Ales Bulc, CEO of Global Bioenergies GmbH, concludes: "We thank the BMBF, as well as the Projektträger Jülich in charge of the detailed evaluation of the technology, for their renewed support. We are presently intensifying our efforts to have our Demo plant up and running this autumn."
About GLOBAL BIOENERGIES
Global Bioenergies is one of the few companies worldwide, and the only one in Europe, that is developing a process to convert renewable resources into hydrocarbons through fermentation. The Company initially focused its efforts on the production of isobutene, one of the most important petrochemical building blocks that can be converted into fuels, plastics, organic glass and elastomers. Global Bioenergies continues to improve the performances of its process, operates its industrial pilot, builds its demo plant in Germany, and prepares the first full-scale plant through a Joint-Venture with Cristal Union, named IBN-One. The company also replicated its achievement to propylene and butadiene, two members of the gaseous olefins family, key molecules at the heart of petrochemical industry. Global Bioenergies is listed on Alternext, Euronext Paris (FR0011052257 - ALGBE).
Should you like to be kept informed, subscribe to our news feed on
www.global-bioenergies.com
Follow us on Twitter: @GlobalBioenergi
Contact
GLOBAL BIOENERGIES
Thomas BUHL
Head of Business Development
Phone: +33 (0)1 64 98 20 50
Email: [email protected]
GLOBAL BIOENERGIES PRESS RELEASE http://hugin.info/166909/R/2025300/752666.pdf
HUG#2025300


Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Anta Sports Expands Global Footprint With Strategic Puma Stake
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Washington Post Publisher Will Lewis Steps Down After Layoffs
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO 



